Advertisement
Advertisement

NGNE

NGNE logo

Neurogene, Inc. Common Stock

32.62
USD
Sponsored
+1.08
+3.42%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

31.08

-1.54
-4.73%

Neurogene, Inc. Common Stock Profile

About

Neurogene Inc. is a clinical-stage company which bring life-changing genetic medicines to patients and families affected by rare neurological diseases. Neurogene Inc., formerly known as Neoleukin Therapeutics Inc., is based in NEW YORK.

Info & Links

CEO

Rachel McMinn

Headquarters

535 W 24TH STREET, 5TH FLOOR
NEW YORK, NY 10011, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.neurogene.com

Auditor

Deloitte & Touche LLP

Share holders

11

Employees

131

Neurogene, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

485.28M

Enterprise Value

381.45M

Enterprise Value/EBITDA(ttm)

-3.64

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.25

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-32.99%

Return on Invested Capital(ttm)

-33.05%

Return on Assets(ttm)

-30.39%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-104.77M

Net Income Available to Common(ttm)

-90.35M

Diluted EPS(ttm)

-4.24

Share Statistics

Beta (5Y Monthly)

1.56

52-Week Change

110.32%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

15.57M

Dividend Yield

0.00%

Float4

13.76M

% Held by Insiders

11.64%

% Held by Institutions

52.37%

Balance Sheet

Total Cash(mrq)

269.01M

Total Cash Per Share(mrq)

17.27

Total Debt(mrq)

19.00K

Total Debt/Equity(mrq)

0.01%

Current Ratio(mrq)

16.56%

Quick Ratio(mrq)

16.56%

Book Value Per Share(mrq)

17.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.62

Free Cash Flow(ytd)

-78.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement